Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs Zeuss

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, Zeuss a 79. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

Zeuss

#85 · Grade B · Fair Price

Est. first month

From $125/mo (compounded)

Save ~91% vs brand-name
Get this deal Full Zeuss review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 79 an est. $99/mo first month, with no teaser step-up baked in. Zeuss isn't out of it: Shoppers who want the only one-time-purchase, no-subscription compounded GLP-1 model.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDZeuss
Value Score89 (A)79 (B)
Est. first month$99/moFrom $125/mo (compounded)
Save vs brand-name~93%~91%
Semaglutide$99/moFrom $125/mo (compounded)
Tirzepatide$139/moFrom $175/mo (compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
87
bmiMD: 95. Zeuss: 87.
84
No Teaser-Rate Bait
72
bmiMD: 84. Zeuss: 72.
98
Nationwide Availability
45
bmiMD: 98. Zeuss: 45.
94
Both Molecules
92
bmiMD: 94. Zeuss: 92.
82
Easy Cancellation
95
bmiMD: 82. Zeuss: 95.
70
Reputation
63
bmiMD: 70. Zeuss: 63.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

Zeuss

Zeuss is a multi-vertical telehealth platform offering compounded semaglutide and tirzepatide for weight loss alongside TRT, HRT, skin, and hair services.

Why it's a deal

  • One-time-purchase model with no subscription — genuinely rare among DTC GLP-1 providers
  • Publishes the FDA compounded-medication disclaimer
  • Names both 503A and 503B compounding pathways — uncommon transparency
  • Bundled pricing covers provider review, meds, and cold-chain shipping with no hidden fees
  • Full refund if a physician can't prescribe

The fine print

  • 503A pharmacy partner not named (only generic '503A and 503B state-licensed' framing)
  • LegitScript certification not mentioned
  • No named medical director or physician leadership
  • Full states-served list not disclosed
  • Corporate legal entity not disclosed
Get the bmiMD deal Get the Zeuss deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to Zeuss.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.